Inventor · disambiguated record
Daniel A. Soltis
Also filed as: SOLTIS DANIEL A
8 granted patents·7 pending applications·31 citations·filing 2001–2018
83Inventor score
Top patents by PatentIndex Score
15 records- 0188US9109007B2MHC-I restricted epitopes containing non-natural amino acid residuesKYLE DONALD J·Filed 2011·Granted Aug 18, 2015·10 cites·10 claims
- 0285US7429382B2Antibodies that bind cell-associated CA 125/O772P and methods of use thereofCORIXA CORP·Filed 2003·Granted Sep 30, 2008·17 cites·50 claims
- 0375US9549972B2MHC-I restricted epitopes containing non-natural amino acid residuesPURDUE PHARMA LP·Filed 2015·Granted Jan 24, 2017·1 cites·8 claims
- 0475US8124086B2Antibodies that bind cell-associated CA 125/O772P and methods of use thereofALBONE EARL F·Filed 2008·Granted Feb 28, 2012·2 cites·15 claims
- 0570US8299230B2Nucleic acid molecules encoding antibodies that bind cell-associated CA 125/O772PALBONE EARL F·Filed 2012·Granted Oct 30, 2012·1 cites·2 claims
- 0666US9676866B2Antibodies that bind cell-associated CA 125/O772PPURDUE PHARMA LP·Filed 2014·Granted Jun 13, 2017·0 cites·15 claims
- 0765US2019106508A1Antibodies that bind cell-associated ca 125/o772pPURDUE PHARMA LP·Filed 2018·Application pending·0 cites
- 0862US10149896B2MHC-I restricted epitopes containing non-natural amino acid residuesPURDUE PHARMA LP·Filed 2017·Granted Dec 11, 2018·0 cites·9 claims
- 0961US2018105601A1Antibodies That Bind Cell-Associated CA 125/O772PPURDUE PHARMA LP·Filed 2017·Application pending·0 cites
- 1059US2013281673A1Antibodies that bind cell-associated ca 125/o772pPURDUE PHARMA LP·Filed 2012·Application pending·0 cites
- 1153US11401345B2Humanized antibodies targeting human tissue factorPURDUE PHARMA LP·Filed 2018·Granted Aug 2, 2022·0 cites·19 claims
- 1246US2004136980A1Thrombopoietin(tpo) synthebody for stimulation of platelet productionFiled 2002·Application pending·0 cites
- 1346US2006099202A1Immunoglobulin construct containing tumor- specific p53bp2 sequenes for eliciting an anti-tumor responseEURO CELTIQUE SA·Filed 2002·Application pending·0 cites
- 1442US2004143101A1Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor responseFiled 2002·Application pending·0 cites
- 1537US2004030103A1Anti-idiotype inducing antibodies, comprising at least one epitope from angiodenin, for the inhibition of angiogenesisFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel A. Soltis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →